Lumos Diagnostics Holdings Ltd.
OTC: LDXHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Douglas Ward
- Headquarters
- Melbourne, Australia
- IPO year
- 2021
- Market cap
- $61.1M
- Website
- https://lumosdiagnostics.com
Loading LDXHF…
Loading profile data…Frequently asked questions about LDXHF
What does Lumos Diagnostics Holdings Ltd. (LDXHF) do?
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx,...
Where does LDXHF trade?
Lumos Diagnostics Holdings Ltd. (LDXHF) trades on the Other OTC.
What sector is LDXHF in?
Lumos Diagnostics Holdings Ltd. (LDXHF) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Lumos Diagnostics Holdings Ltd.?
Douglas Ward is the chief executive officer of Lumos Diagnostics Holdings Ltd. (LDXHF).
Where is Lumos Diagnostics Holdings Ltd. headquartered?
Lumos Diagnostics Holdings Ltd. is headquartered in Australia.
Does LDXHF pay a dividend?
Lumos Diagnostics Holdings Ltd. (LDXHF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LDXHF go public?
Lumos Diagnostics Holdings Ltd. (LDXHF) completed its initial public offering in 2021.